Most people go home the same day after a PRRT infusion, and the first week or two involves managing mild side effects like nausea and fatigue while following radiation safety precautions around family members. PRRT (peptide receptor radionuclide therapy) is delivered in a series of four cycles spaced roughly 6 to 10 weeks apart, so “recovery” isn’t a single event. It’s a repeating process that unfolds over several months. Here’s what each phase typically looks like.
The Day of Treatment
A single PRRT session takes most of a day. Before the radioactive drug is infused, you receive an amino acid solution through a separate IV line. This solution, containing lysine and arginine, helps protect your kidneys by reducing how much radiation they absorb. The amino acid infusion runs for about four hours, starting 30 minutes before the treatment itself begins. You’ll also get anti-nausea and anti-inflammatory medications beforehand.
The amino acid infusion is one of the more uncomfortable parts of the day for many patients. Nausea and vomiting are its most common side effects, separate from the radioactive treatment itself. In rare cases, if the IV leaks into surrounding tissue, it can cause skin irritation or blistering at the infusion site. Let your care team know immediately if you notice swelling, pain, or redness around the IV.
In the United States, PRRT is typically performed as an outpatient procedure. You’ll spend a half or full day at the treatment center and go home afterward. Overnight stays are rare.
The First Few Weeks: Common Side Effects
About 72% of patients experience some side effects during their course of treatment. The two most common are nausea (affecting roughly 28% of patients) and fatigue (about 23%). Patient surveys paint a slightly different picture, with fatigue reported even more frequently, around 58%, and nausea and vomiting at about 27%. The difference likely reflects how patients experience these symptoms in daily life versus how they’re recorded in clinical settings.
Other side effects that show up in the first days and weeks include abdominal pain (around 16% of patients), diarrhea, and vomiting. These tend to be mild to moderate and improve on their own. Fatigue can linger longer than the digestive symptoms, sometimes lasting a week or more after each cycle. Some people feel relatively normal within a few days, while others notice a cumulative tiredness that builds over successive treatment cycles.
If you’re struggling with appetite or nausea during this time, eating small meals on a schedule rather than waiting until you feel hungry can help. Cold or room-temperature foods are often more tolerable because they produce fewer strong smells. Aim for at least 64 ounces (about 2 liters) of fluids per day to help your body flush the radioactive material and stay hydrated.
Radiation Safety Precautions at Home
Because the treatment involves a radioactive substance, your body emits low levels of radiation for a period after each infusion. Most of the drug leaves your body through urine, so bathroom hygiene is the biggest practical concern. You should double-flush the toilet after each use, wash your hands thoroughly, and use a separate bathroom if one is available. Male patients are typically asked to sit down when urinating to reduce splashing and contamination.
You won’t need to restrict private car travel, but public transport should be limited to one hour on the day you leave the treatment center. Precaution periods for close contact with family members, coworkers, and the general public vary by facility, but the key window begins about 8 hours after your infusion for outpatients. Your treatment team will give you specific timeframes for how long to maintain extra distance from children, pregnant women, and others in your household. These restrictions typically last only a few days.
Blood Work and Ongoing Monitoring
PRRT can affect your blood cell counts because the radiation impacts bone marrow. Your care team will check your complete blood counts at baseline before treatment, then again 2 to 4 weeks after each cycle. If any values drop below normal, testing continues until they recover. Low counts of white blood cells, red blood cells, or platelets are possible, and these changes can accumulate with each treatment cycle. This is one of the main reasons the interval between cycles is 6 to 10 weeks: your body needs time to recover before the next dose. If blood counts haven’t bounced back, the gap between cycles can be extended to as long as 16 weeks.
Liver function (enzymes, bilirubin, albumin) is also monitored at baseline and with each cycle. Kidney function is tracked because, despite the protective amino acid infusion, the kidneys still absorb some radiation over the course of treatment.
Post-Treatment Imaging
You may have a scan taken about 24 hours after each infusion. This post-therapy scan shows where the radioactive drug has traveled in your body and how well it’s concentrating in tumor sites. It uses a specialized camera that detects the radiation emitted by the treatment itself, so no additional radioactive tracer is needed. While this scan can provide useful information, it’s not a required part of the standard FDA-approved protocol and isn’t performed at every center.
The scans used to evaluate whether treatment is working, such as CT, MRI, or a specialized PET scan, are typically scheduled at separate intervals determined by your oncologist. These follow-up imaging studies help assess whether tumors have shrunk, stabilized, or progressed.
The Full Treatment Timeline
The standard PRRT course consists of four cycles. With intervals of 6 to 10 weeks between each dose, the entire treatment spans roughly 6 to 10 months from first infusion to last. During this period, you’ll repeat the same process: infusion day, a few days of radiation precautions, a couple of weeks managing side effects, blood work to confirm recovery, then the next cycle.
Many patients notice that side effects become somewhat more predictable with each cycle. You learn your own pattern of fatigue and nausea and can plan around it. Some people continue working between cycles, especially after the first week or so, while others need more downtime. The cumulative effect on blood counts means the later cycles may require a longer recovery window.
Long-Term Risks to Know About
The most serious long-term risk of PRRT is the development of a bone marrow disorder called myelodysplastic syndrome, or a related blood cancer (leukemia). In a long-term follow-up study, this occurred in about 6.7% of patients, with nearly all cases appearing more than four years after treatment. This risk is weighed against the treatment’s benefits: in the same study, 21% of patients had no disease progression at 10 years. Your oncologist factors this long-term risk into the decision to recommend PRRT, particularly for patients who may also receive chemotherapy, which can compound the risk to bone marrow.
Because these complications can emerge years later, periodic blood work continues well beyond your final treatment cycle. Staying on top of follow-up appointments is one of the most important things you can do after completing PRRT.